ASSOCIATION OF INTRAINDIVIDUAL TACROLIMUS VARIABILITY WITH THE DEVELOPMENT OF DE NOVO DONOR-SPECIFIC HLA ANTIBODIES

被引：0
|
作者：
Alexander, Fichtner [1 ]
Claudia, Schroeder [1 ]
Caner, Suesal [2 ]
Britta, Hoecker [1 ]
Susanne, Rieger [1 ]
Tobias, Vinke [1 ]
Jens, Westhoff [1 ]
Rudiger, Waldherr [3 ]
Burkhard, Toenshoff [1 ]
机构：
[1] Univ Childrens Hosp Heidelberg, Heidelberg, Germany
[2] Heidelberg Univ, Inst Immunol, Heidelberg, Germany
[3] Heidelberg Univ, Inst Pathol, Heidelberg, Germany
来源：
PEDIATRIC NEPHROLOGY | 2018年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
P-381
引用
收藏
页码：1956 / 1956
页数：1
相关论文
共 50 条
  • [1] Association of intraindividual tacrolimus variability with the development of de novo donor-specific hla antibodies
    Fichtner, Alexander
    Schmidt, Jeremy
    Suesal, Caner
    Hoecker, Britta
    Rieger, Susi
    Vinke, Tobias
    Toenshoff, Burkhard
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [2] Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
    Maral Baghai Arassi
    Laura Gauche
    Jeremy Schmidt
    Britta Höcker
    Susanne Rieger
    Caner Süsal
    Burkhard Tönshoff
    Alexander Fichtner
    Pediatric Nephrology, 2022, 37 : 2503 - 2514
  • [3] Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
    Arassi, Maral Baghai
    Gauche, Laura
    Schmidt, Jeremy
    Hoecker, Britta
    Rieger, Susanne
    Suesal, Caner
    Toenshoff, Burkhard
    Fichtner, Alexander
    PEDIATRIC NEPHROLOGY, 2022, 37 (10) : 2503 - 2514
  • [4] Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies
    Davis, Scott
    Gralla, Jane
    Klem, Patrick
    Stites, Erik
    Wiseman, Alexander
    Cooper, James E.
    TRANSPLANTATION, 2020, 104 (04) : 881 - 887
  • [5] ASSOCIATION BETWEEN TACROLIMUS VARIABILITY AND DEVELOPMENT OF DONOR-SPECIFIC ANTIBODIES IN PEDIATRIC KIDNEY TRANSPLANTATION
    Caballero Gil, Jose Angel
    Ojea Varona, Silvia
    Lopez-Viota, Julia Fijo
    Bedoya Perez, Rafael
    Sanchez Moreno, Ana
    De La Cerda Ojeda, Francisco
    PEDIATRIC NEPHROLOGY, 2023, 38 : S156 - S156
  • [6] Below the WaterlineuThe Danger of De Novo Donor-Specific HLA Antibodies
    Kokko, K. E.
    Colvin, R. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) : 1077 - 1078
  • [7] Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of de novo anti-HLA donor-specific antibodies in kidney transplant recipients
    Rojas, Aleixandra Mendoza
    Hesselink, Dennis A.
    van Besouw, Nicole M.
    Baan, Carla C.
    van Gelder, Teun
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (12) : 1323 - 1331
  • [8] Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients
    Sonia Solomon
    Adriana Colovai
    Marcela Del Rio
    Nicole Hayde
    Pediatric Nephrology, 2020, 35 : 261 - 270
  • [9] The Impact of Tacrolimus IPV and TTR on the Development of De Novo Donor-specific Antibodies in Kidney Transplant Recipients
    Xu, D.
    Richards, K.
    Zheng, K.
    Patel, H.
    Cardarelli, F.
    Pena, J. A.
    Aala, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 844 - 844
  • [10] De Novo Donor-Specific HLA Antibodies: Biomarkers of Pancreas Transplant Failure
    Mittal, S.
    Page, S. L.
    Friend, P. J.
    Sharples, E. J.
    Fuggle, S. V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (07) : 1664 - 1671
12345